• Je něco špatně v tomto záznamu ?

On the molecular pharmacology of resveratrol on oxidative burst inhibition in professional phagocytes

R. Nosáľ, K. Drábiková, V. Jančinová, T. Perečko, G. Ambrožová, M. Číž, A. Lojek, M. Pekarová, J. Šmidrkal, J. Harmatha,

. 2014 ; 2014 (-) : 706269.

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc15008159

Resveratrol-3,5,4'-trihydroxystilbene-possesses antioxidant activities in vitro. It dose-dependently inhibited the generation of peroxyl, hydroxyl, peroxides, and lipid peroxidation products in cell free systems. Oxidative burst of whole human blood stimulated with PMA, fMLP, OpZ, and A23187 was inhibited in a concentration-dependent way, indicating suppression of both receptor and nonreceptor activated chemiluminescence by resveratrol. Results from isolated human neutrophils revealed that resveratrol was active extracellularly as well as intracellularly in inhibiting the generation of reactive oxygen species. Liberation of ATP and analysis of apoptosis showed that in the concentration of 100 μM, resveratrol did not change the viability and integrity of isolated neutrophils. Western blot analysis documented that resveratrol in concentrations of 10 and 100 μM significantly decreased PMA-induced phosphorylation of PKC α/β II. Dose-dependent inhibition of nitrite production and iNOS protein expression in RAW 264.7 cells indicated possible interference of resveratrol with reactive nitrogen radical generation in professional phagocytes. The results suggest that resveratrol represents an effective naturally occurring substance with potent pharmacological effect on oxidative burst of human neutrophils and nitric oxide production by macrophages. It should be further investigated for its pharmacological activity against oxidative stress in ischaemia reperfusion, inflammation, and other pathological conditions, particularly neoplasia.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc15008159
003      
CZ-PrNML
005      
20150331111925.0
007      
ta
008      
150306s2014 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1155/2014/706269 $2 doi
035    __
$a (PubMed)24672638
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Nosáľ, Radomír $u Institute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, Dúbravská 9, 841 04 Bratislava, Slovakia.
245    10
$a On the molecular pharmacology of resveratrol on oxidative burst inhibition in professional phagocytes / $c R. Nosáľ, K. Drábiková, V. Jančinová, T. Perečko, G. Ambrožová, M. Číž, A. Lojek, M. Pekarová, J. Šmidrkal, J. Harmatha,
520    9_
$a Resveratrol-3,5,4'-trihydroxystilbene-possesses antioxidant activities in vitro. It dose-dependently inhibited the generation of peroxyl, hydroxyl, peroxides, and lipid peroxidation products in cell free systems. Oxidative burst of whole human blood stimulated with PMA, fMLP, OpZ, and A23187 was inhibited in a concentration-dependent way, indicating suppression of both receptor and nonreceptor activated chemiluminescence by resveratrol. Results from isolated human neutrophils revealed that resveratrol was active extracellularly as well as intracellularly in inhibiting the generation of reactive oxygen species. Liberation of ATP and analysis of apoptosis showed that in the concentration of 100 μM, resveratrol did not change the viability and integrity of isolated neutrophils. Western blot analysis documented that resveratrol in concentrations of 10 and 100 μM significantly decreased PMA-induced phosphorylation of PKC α/β II. Dose-dependent inhibition of nitrite production and iNOS protein expression in RAW 264.7 cells indicated possible interference of resveratrol with reactive nitrogen radical generation in professional phagocytes. The results suggest that resveratrol represents an effective naturally occurring substance with potent pharmacological effect on oxidative burst of human neutrophils and nitric oxide production by macrophages. It should be further investigated for its pharmacological activity against oxidative stress in ischaemia reperfusion, inflammation, and other pathological conditions, particularly neoplasia.
650    _2
$a zvířata $7 D000818
650    _2
$a buněčné linie $7 D002460
650    _2
$a separace buněk $7 D002469
650    _2
$a viabilita buněk $x účinky léků $7 D002470
650    _2
$a scavengery volných radikálů $x metabolismus $7 D016166
650    _2
$a lidé $7 D006801
650    _2
$a peroxidace lipidů $x účinky léků $7 D015227
650    _2
$a luminiscenční měření $7 D008163
650    _2
$a luminol $x metabolismus $7 D008165
650    _2
$a myši $7 D051379
650    _2
$a neutrofily $x účinky léků $x metabolismus $7 D009504
650    _2
$a synthasa oxidu dusnatého, typ II $x metabolismus $7 D052247
650    _2
$a dusitany $x metabolismus $7 D009573
650    _2
$a fagocyty $x účinky léků $x enzymologie $x metabolismus $7 D010586
650    _2
$a proteinkinasy $x metabolismus $7 D011494
650    _2
$a reaktivní formy kyslíku $x metabolismus $7 D017382
650    _2
$a respirační vzplanutí $x účinky léků $7 D016897
650    _2
$a stilbeny $x farmakologie $7 D013267
650    _2
$a tetradekanoylforbolacetát $x farmakologie $7 D013755
650    _2
$a látky reagující s kyselinou thiobarbiturovou $x metabolismus $7 D017392
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Drábiková, Katarína $u Institute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, Dúbravská 9, 841 04 Bratislava, Slovakia.
700    1_
$a Jančinová, Viera $u Institute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, Dúbravská 9, 841 04 Bratislava, Slovakia.
700    1_
$a Perečko, Tomáš $u Institute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, Dúbravská 9, 841 04 Bratislava, Slovakia.
700    1_
$a Ambrožová, Gabriela $u Institute of Biophysics AS CR v.v.i. Královopolská 135, 612 65 Brno, Czech Republic. $7 gn_A_00005440
700    1_
$a Číž, Milan $u Institute of Biophysics AS CR v.v.i. Královopolská 135, 612 65 Brno, Czech Republic.
700    1_
$a Lojek, Antonín $u Institute of Biophysics AS CR v.v.i. Královopolská 135, 612 65 Brno, Czech Republic.
700    1_
$a Pekarová, Michaela $u Institute of Biophysics AS CR v.v.i. Královopolská 135, 612 65 Brno, Czech Republic.
700    1_
$a Šmidrkal, Jan $u Institute of Chemical Technology, Faculty of Food and Biochemical Technology, Technická 5, 166 28 Praha 6, Czech Republic.
700    1_
$a Harmatha, Juraj $u Institute of Organic Chemistry and Biochemistry AS CR v.v.i., Flemmingovo nám. 2, 166 10 Praha 6, Czech Republic.
773    0_
$w MED00180520 $t Oxidative medicine and cellular longevity $x 1942-0994 $g Roč. 2014, č. - (2014), s. 706269
856    41
$u https://pubmed.ncbi.nlm.nih.gov/24672638 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20150306 $b ABA008
991    __
$a 20150331112155 $b ABA008
999    __
$a ok $b bmc $g 1065432 $s 890959
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2014 $b 2014 $c - $d 706269 $i 1942-0994 $m Oxidative medicine and cellular longevity $n Oxid Med Cell Longev $x MED00180520
LZP    __
$a Pubmed-20150306

Najít záznam

Citační ukazatele

Možnosti archivace